US equities |
META $624.45 ▼-0.97% TSLA $405.54 ▲+3.55% MU $924.53 ▲+2.31% NVDA $217.52 ▲+0.70% SPCX $149.78 ▲+1.96% AMD $556.32 ▲+4.71% SNDK $1,292.50 ▲+2.94% INTC $93.12 ▲+2.93%
FinancialContent

Latest News about Phase 3 Clinical Trial

Recent news which mentions Phase 3 Clinical Trial

UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
Tickers AWKNF
Tags News University of Exeter Benzinga
From Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
Tags Cannabis News FDA
From Benzinga
Compass Pathways Will Lead Two Concurrent Phase 3 Trials On Psilocybin-Assisted Therapy For Depression
Tickers CMPS
Tags Markets Phase 3 Clinical Trial Market News
From Benzinga